{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-073213","form_type":"8-K","ticker":"CVKD","cik":"0001937993","company_name":"Cadrenal Therapeutics, Inc.","filed_at":"2026-06-29T21:19:24+00:00","discovered_at":"2026-06-29T21:20:00.865276+00:00","generated_at":"2026-06-29T21:20:33.364600+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Cadrenal Therapeutics appoints John P. Sharp interim CFO; board member resigns, classes realigned","bullets":["John P. Sharp appointed Interim CFO effective June 25, 2026, replacing Quang X. Pham.","Compensation: $455/hour, up to 24 hours/week via Lohman & Associates Master Services Agreement.","Steven Zelenkofske resigns from board effective June 30, 2026; no disagreement cited.","Board realigned: Glynn Wilson moved from Class I to Class III director to balance classes."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-073213","json":"https://secwatch.observer/filing/0001213900-26-073213.json","markdown":"https://secwatch.observer/filing/0001213900-26-073213.md","text":"https://secwatch.observer/filing/0001213900-26-073213.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1937993/000121390026073213/0001213900-26-073213-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1937993/000121390026073213/ea0296328-8k_cadrenal.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T21:20:33.364600+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}